Human extraocular vascular endothelial cell cultures, isolated from aorta (17-year-old male donor), umbilical vein (newborn male donor) and dermal microvasculature (30-year-old female donor), were purchased from Cascade Biologics (Portland, OR). Three human retinal microvascular endothelial cell lines, isolated from three different donors (donor 1, 17-year-old female; donor 2, 18-year-old male, and donor 3, 14-year-old male) were obtained from the Applied Cell Biology Institute (Kirkland, WA). All endothelial cells were cultured in MCDB-131 medium (product number M-8537; Sigma-Aldrich, St. Louis, MO), supplemented with 10 mM sodium bicarbonate, 10% fetal bovine serum (FBS) and endothelial growth factors and antibiotics (EGM-MV2 BulletKit, with omission of hydrocortisone and FBS; Clonetics-Cambrex Inc., East Rutherford, NJ), at 37°C and at 5% CO2. Human foreskin fibroblasts, also purchased from Cascade Biologics, were grown in DMEM (product number 12100; Invitrogen-Gibco Inc., Carlsbad, CA), supplemented with 40 mM sodium bicarbonate, 10% heat-inactivated FBS, 50 U/mL penicillin, and 50 μg/mL streptomycin (product number 15070; Invitrogen-Gibco Inc.), under identical conditions. Cell cultures were at passages 3 to 8 when used in the [3H]-uracil–incorporation tachyzoite replication assay.